Administration of α-CGRP attenuated TAC-induced increased activation of sirt1 and AMPK, and inhibited oxidative stress and apoptotic cell death in TAC mice who received α-CGRP. The gene discussed is SIRT1; the disease is persistent truncus arteriosus.